Liver microsomes contain two carnitine acyltransferase activities. One of these has properties closely corresponding to those of 88 kDa mitochondrial carnitine palmitoyltransferase-1 (CPT-1). Anti-~
cent protein, etomoxir, 2-[6-(4-chlorophenoxy) hexyl]oxirane carboxyic acid. N,ph, 2,4-dinitrophenyl 'To whom correspondence should be addressed (e-rnail saggerson (aibiochern ucl ac uk) sera against CPT-1 cross-react with an 88 kDa microsomal protein, suggesting that CPT-1 may be targeted to both microsomal and mitochondrial membranes. However, no experiments using cDNAs corresponding to CPT-1 involving in vitro translation with microsomes or involving in vivo COS-1 cell transfection provided any evidence to support this hypothesis.
Introduction: the discovery of two microsomal carnitine acyltransferases
Rat liver microsomes were first reported to contain carnitine acyltransferase (CAT) 
activity in 1976
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[l] but it was not until 1990 that Lilly et al. [2] investigated the effect of malonyl-CoA on microsomal CAT. C A T activity in 'intact' microsomes from both rough or smooth endoplasmic reticulum fractions was shown to be highly sensitive to inhibition by malonyl-CoA (IC5, 5 pM). This malonyl-CoA-sensitive C A T was most active with medium-chain-length fatty acyl-CoA substrates, e.g. decanoyl-CoA [2] . At that time (1990) the possibility that microsomes might contain more than one C A T activity had not been considered. Subsequently Murthy and Beiber [3] purified a C A T activity from rat liver microsomes. T h e molecular mass of this enzyme on SDS/PAGE was 50.1 kDa [3] or 53 kDa [4] and gel filtration indicated a monomeric protein of molecular mass 54.3 kDa. However, unlike the C A T activity that had been observed in 'intact' microsomes [2] , this purified C A T was not inhibited by malonyl-CoA, and 2-[6-(4-chlorophenoxy)hexyl]oxirane carboxyl-CoA (etomoxiryl-CoA) (see below) was only a weak inhibitor [4] .
During 1994-95 two studies [5, 6] established the presence of two CATS in rat liver microsomes, which have been designated [7] as CAT, (inhibitable by malonyl-CoA) and CAT, (insensitive to malonyl-CoA). After solubilization of microsomal proteins with deoxycholate, CAT, and CAT, could be clearly separated by gel-filtration or anion-exchange chromatography [6] . T h e CAT, and CAT, gel-filtration fractions had quite distinct activity profiles when assayed with a range (C, to C16) of fatty acyl-CoA substrates [6] and, unlike CAT,, the activity of CAT, could be irreversibly inhibited by the 2-oxirane derivatives 2-tetradecylglycidyl-CoA [5] and etomoxiryl-CoA [6] . Additionally, whereas CAT, activity was shown to be very unstable in octyl glucoside [6] , CAT, had previously been found to be stable in this detergent [4] . CAT, activity was mainly latent in ' intact' microsomes and was readily released on freeze-thawing or on sonicating liver microsomes, leading to the conclusion that CAT, is derived from the lumen of the endoplasmic reticulum. This released activity cross-reacted with an antibody against the C A T that had previously been purified [4] (molecular mass approx. 54 kDa) and, on gel filtration in the presence of deoxycholate, CAT, was found in a peak of molecular mass approx. 60 kDa [6] . It is most likely that CAT, is the malonyl-CoA-insensitive enzyme originally purified by Chung and Bieber [4] . Microsomal CAT, activity was not released by freeze-thawing or by sonication and remained in the 'membrane residue' after these treatments. However, it was solubilized by deoxycholate [6] . It was concluded that CAT, was a membrane-bound enzyme and, because its activity was readily measurable in freshly isolated 'intact ' microsomes, that its catalytic site was directed towards the cytosolic side of the membrane.
T h e contribution of microsomal CAT, to liver malonyl-CoA-inhibitable C A T activity is not trivial. It was estimated to be equivalent to 95 ()(, [6] or 38 "4) [8] of the mitochondrial activity when palmitoyl-CoA was the assay substrate, or up to almost double the mitochondrial activity when decanoyl-CoA was used in assays [6] .
Similarities and dissimilarities between microsomal CAT, and mitochondrial carnitine pal mitoy ltransferase (C PT) I Liver microsomal CAT, and mitochondrial outer membrane C P T I share the key property of being reversibly inhibited by malonyl-CoA, the product of the acetyl-CoA carboxylase reaction. Similarly, both enzymes are irreversibly inhibited by CoA esters of 2-oxirane compounds (see above) and are inhibited by sulphonylurea drugs [9] . During fasting, the specific activities of CAT, and C P T I in microsomal and mitochondrial outer membranes respectively were both increased [10, 11] , and this was accompanied by a decrease in sensitivity (increased ICs,,) of both activities to malonyl-CoA, which has been attributed to changes in membrane lipid composition [ 10,121. Increased membrane fluidity, whether induced by increased temperature or by chemical agents, also resulted in a decreased sensitivity of mitochondrial C P T I to malonyl-CoA [ 13-1 51 ; a similar loss of sensitivity of CAT, to malonyl-CoA with increased temperature was seen when CAT, was assayed in situ in microsomes [lo] .
However, despite these striking similarities in properties, there are some significant differences in the properties of microsomal CAT, and of mitochondrial C P T I. With the enzymes in situ in their respective membranes an Arrhenius plot ( 5 4 0 "C) for CAT, was linear (r = -0.999) [lo] , whereas that for C P T I was clearly biphasic [15, 16] . As discussed in [lo] , it is difficult to ascribe these phenomena to differences in the membranes themselves. With regard to kinetic properties, microsomal CAT, has a lower IC,, for malonyl-CoA than C P T I [17] and the KnS of CAT, for the substrate decanoyl-CoA (with BSA present) is significantly ( P < 0.001) lower (6.8k0.3 pM versus 32.5f5.0pM) than the K O , of C P T I [6] . A difference in the IC,, for malonylCoA could simply reflect differences in membrane environment (see above). However, the K O , of CAT, for decanoyl-CoA does not seem to be a property that is particularly sensitive to environment. This parameter was identical for CAT, when in the native membrane, when solubilized by deoxycholate and when reconstituted into phosphatidylcholine liposomes [6] . However, by far the most striking difference between microsomal CAT, and mitochondrial C P T I is that, whereas CAT, can readily be solubilized from microsomes with 7 m M deoxycholate /20 (v/v) glycerol [6] in good yield and with excellent longterm stability, extraction of mitochondrial outer membranes under identical conditions results in a rapid loss of 85-90% of C P T I activity [6] . It is difficult to reconcile this finding with the conjecture (see below) that CAT, and C P T I are totally identical proteins.
T h e ability to solubilize and then reconstitute microsomal CAT, into phospholipid vesicles of known composition has been of considerable use experimentally [6, 10] .
The possibility that CAT, is CPT I that is alternatively targeted to the endoplasmic reticulum
Attempts to purify CAT, protein to homogeneity have so far been unsuccessful, so its subunit size is inferred from labelling experiments. T h e first attempt at this approach was by Murthy and Pande [5] , who concluded that CAT, corresponded to a [3H]etomoxir-labelled polypeptide of molecular mass approx. 47 kDa. However, when rat livers were perfused with 2,4-dinitrophenyl (N,ph)-etomoxir the major polypeptide band that was subsequently detected after the isolation of microsomes, SDS/PAGE and Western blotting with an anti-N,ph antibody had a molecular mass of 88 kDa [8] . Similarly, although direct treatment of liver microsomal membrane residues with N,ph-etomoxiryl-CoA labelled several protein bands, including one of molecular mass 49-50 kDa, which is similar to the size assigned to CAT, by [5] , a labelled band of molecular mass 88 kDa was again prominent [7] . After fasting (24 h), which increased the specific activity of microsomal CAT, 2.9-fold, there was a 2.7-fold increase in the abundance (relative to membrane protein) of the 88 kDa band but a 2.0-fold decrease in the abundance of the 49-50 kDa band (N. M.
Broadway and E. D. Saggerson, unpublished work) . These findings are difficult to reconcile with the suggestion of a 47-50 kDa subunit size for CAT, [S] but are not at variance with the possibility that CAT, is a 88 kDa protein.
Antipeptide antibodies raised against three linear epitopes (N, Val,,-Lys,, ; L, Lys,,-Gin,,, ; C, Arg,,,-Lys,,,) within liver C P T I all crossreacted with a 88 kDa polypeptide from rat liver microsomes and peroxisomes [8, 18] . With the same anti-C antibody, Broadway et al. [7] also observed a strong 88 kDa immunoreactive band in liver microsomes from fed and fasted adult rats and from suckling rats, the abundance of which was positively correlated with changes in CAT, specific activity between these three states [7] . When liver mitochondrial outer-membrane and microsomal proteins were run in the same SDS/PAGE lane before immunoblotting with the anti-C antibody, consistently only one band in the 88 kDa region was seen, with no sign of a 'doublet' (N. M. Broadway and E. D. Saggerson, unpublished work). This suggested a complete or very near identity of the size of the 88 kDa microsomal band with that of C P T I . After partial purification of microsomal CAT, by solubilization with deoxycholate followed by gel filtration, the 88 kDa immunoreactive band was again seen strongly (N. M . Broadway and E. D. Saggerson, unpublished work). Taken together with the observations with N,ph-etomoxir, these findings strongly suggested that microsomal CAT, contained a polypeptide of molecular mass 88 kDa that is either identical to, or remarkably similar to, C P T I.
We have considered the possibility that microsomal malonyl-CoA-inhibitable CAT could be accounted for by contamination from mitochondria. Rough microsomal membranes were used that had been purified by sucrose-density centrifugation. On the basis of contamination by monoamine oxidase, Broadway and Saggerson [6] claimed that less that 8 % of the microsomal CAT, activity could be C P T I from mitochondrial outer membranes. However, recent studies have shown that C P T I activity is distributed non-uniformly within the mitochondrial outer membrane and is particularly enriched in a membrane fraction derived from contact sites [19] . Therefore the distribution of monoamine oxidase might not accurately reflect that of C P T I ; accordingly, we have performed preliminary experiments to quantify the contamination of purified microsomal fractions by porin (a protein that is known to be concentrated within the contact-site region of the published work) we have investigated whether C P T I could be targeted into the endoplasmic reticulum membrane in vitro by performing transcription/translation with cDNA species corresponding to the full coding sequence of liver C P T I or to a truncated liver C P T I (residues 1-328).
35S-labelled translation products were generated with nuclease-treated rabbit reticulocyte lysate in the presence of import-competent canine pancreatic microsomes. T h e test for ' true' insertion of the 35S-labelled translation product into membranes was resistance to extraction by 'alkaline carbonate', Na,CO, (0.1 M, p H l l . S ) , for 60 min on ice, a criterion that has been generally used previously to discriminate integral membrane proteins from peripheral and luminal proteins [2&23] . A substantial proportion of truncated liver C P T I was found in the alkaline carbonate pellet [7] . This seemed to be a relatively specific phenomenon because essentially no 35S-labelled products were found there when cDNA species corresponding to a similarly truncated muscle C P T I or to residues 1-163 of the latent form, C P T I I, were transcribed/translated in the presence of canine pancreatic microsomes. These observations might imply an authentic insertion of C P T I into the endoplasmic reticulum. However, although still readily measurable, far less of the translated full-length liver C P T I was found in the alkaline carbonate pellet. Additionally, deletion of both of the transmembrane regions of C P T I that might traverse the mitochondrial outer membrane (residues 54-74 and 104-121) [24] did not diminish the appearance of the truncated or the full-length translation products in the alkaline carbonate pellet. Furthermore, when a cDNA for the truncated liver C P T I from which the second transmembrane region (residues 104-1 21) had been deleted and that had been further mutated to give potential N-glycosylation sites at residues 30 and 182 was transcribed/translated, the 35S-labelled translation product showed no evidence of glycosylation. This should have occurred if the polypeptide had inserted with the remaining transmembrane region (residues 54-74) spanning the membrane. These observations are at variance with authentic membrane insertion but might still be consistent with some form of peripheral association. Finally, however, after transcription/ translation of the truncated or full-length liver C P T I forms, the canine pancreatic microsomes were fractionated by sucrose-density centrifugation to reveal that the '%-labelled translation products seemed to form an alkaline-carbonateresistant complex that was not found in gradient fractions where true transmembrane insertion (as judged by glycosylation of an authentic microsomal membrane protein, arylacetamide deacetylase [25] ) occurred. Hence, with this in vitro approach we have found no evidence for the association of C P T I with microsomal membranes.
In other recent studies (N. M. Broadway, R. J. Pease, G. Birdsey and E. D. Saggerson, un- published work) we have used an in vivo approach to investigate the possibility that liver C P T I might be 'promiscuous' in its targeting to cellular organelles. COS-1 cells were transiently transfected with a cDNA construct to express a fusion protein in which enhanced green fluorescent protein was fused to the C-terminus of the full coding sequence of liver C P T I ( C P T I-EGFP). Confocal microscopy showed that C P T I-EGFP was expressed in a punctate manner that clearly colocalized with the fluorescence of Mitotracker (a dye that accumulates in mitochondria). However, when transfected cells were stained for the rough endoplasmic reticulum protein calnexin, the distribution of calnexin was much more diffuse than that of C P T I-EGFP and there was no evidence for co-localization with C P T I-EGFP. Again, these studies lend no support to the notion that C P T I might be targeted to the endoplasmic reticulum.
Cleavage by protease K of the extreme Nterminus of liver C P T I markedly increased (by 10-fold) its immunoreactivity with the anti-N antibody [26] . Reaction of the same antibody with the microsomal 88 kDa polypeptide was also disproportionately high compared with the corresponding SDS/PAGE band from mitochondrial outer membranes [8, 18] . These two findings led Fraser et al. [8] to speculate that such a proteolytic modification of the N-terminus of C P T I might be responsible for the targeting of C P T I to microsomes instead of to the mitochondria. However, this seems unlikely because (see above) microsomal CAT, is more sensitive to malonyl-CoA
[17], whereas C P T I that has undergone proteolytic cleavage by protease K is less sensitive to malonyl-CoA [26] . Further, whereas the cDNA species used in our translation studies in vitro coded for the complete N-terminus, it would be surprising if the lack of this small modification could completely abolish microsomal import of the protein.
It has also been speculated [8] that the targeting of the same protein (e.g. C P T I) to different cytosol-facing membranes such as the mitochondrial outer membrane and the endoplasmic reticulum might involve the use of splice variant mRNA species that differ only in their 5'-untranslated regions but are in some way important in directing to site-specific translation regions within the cell. T h e 5'-untranslated region of the liver C P T I gene contains two exons that can be alternatively spliced [27] . It is possible that the omission of these from the cDNA used in our transfection of COS-1 cells could have influenced the targeting of C P T I-EGFP but this provides no explanation for the failure of C P T I translation products to insert into microsomes in vitro.
Clearly, further studies are needed to clarify the relationship between microsomal CAT, and mitochondrial C P T I.
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